My Prostate Cancer was found incidentally — does that change my prognosis

Incidental Prostate Cancer Discovery: What It Means for Your Prognosis

Great question. Yes, how your cancer was discovered does matter, but perhaps not in the way you might expect. Let me explain the clinical reasoning and what this means for your situation.

How Doctors Think About Incidental Findings

When prostate cancer is found "incidentally" (by accident, during a procedure for another reason), it typically means:

• Cancer was discovered during a transurethral resection of the prostate (TURP) for benign prostatic hyperplasia (BPH)
• Or found unexpectedly during another urological procedure
• You didn't have symptoms that prompted the search

According to NCCN Guidelines, incidental findings are classified by how much of the tissue removed contained cancer:

• T1a: 5% or less of removed tissue is cancer
• T1b: More than 5% of removed tissue is cancer
• T1c: Cancer found because of an elevated PSA level (not truly "incidental")

Does This Change Your Prognosis?

The short answer: The discovery method itself doesn't determine prognosis—but what the cancer looks like does.

Here's what matters more:

What DOES affect your prognosis:

• Gleason score (how aggressive the cancer cells appear under a microscope)
• PSA level at diagnosis
• Stage of the cancer (how far it has spread)
• Your age and life expectancy (critical factor)
• Risk group classification (very low, low, intermediate, high, or very high risk)

What DOESN'T significantly change:

• Simply the fact that it was found incidentally rather than through screening

The Clinical Decision-Making Framework

According to NCCN Guidelines for Early-Stage Prostate Cancer, your care team will now:

1. Determine your risk group using your PSA, Gleason score, and stage
2. Estimate your life expectancy (this is crucial—see below)
3. Consider molecular biomarker tests if you're in intermediate or higher risk groups
4. Discuss active surveillance vs. treatment based on your specific risk profile

Why Life Expectancy Matters So Much

This is where incidental discovery becomes relevant. NCCN Guidelines emphasize that life expectancy is a key factor in deciding your treatment path:

• If you have ≤5 years life expectancy: Observation (watchful waiting) is often recommended, even for intermediate-risk cancer
• If you have 5-10 years life expectancy: Your care team will carefully weigh active surveillance vs. treatment
• If you have >10 years life expectancy: More aggressive treatment options are typically considered

Because your cancer was found incidentally (often in older men with other health conditions), your overall life expectancy becomes especially important in treatment planning.

What Questions to Ask Your Oncology Team

To understand YOUR specific situation:

1. "What is my Gleason score, PSA level, and stage? What risk group do I fall into?"

   • This tells you how aggressive your cancer is

2. "What is my estimated life expectancy, and how does that affect my treatment options?"

   • This is the most important factor for incidental cancers

3. "Based on my risk group and life expectancy, do you recommend active surveillance, observation, or treatment? Why?"

   • Different approaches fit different situations

4. "Are there molecular biomarker tests that would help guide my decision?"

   • Tests like Decipher, Genomic Prostate Score, or Prolaris can provide more precise risk estimates

5. "What would happen if I chose to monitor rather than treat right now?"

   • Understanding the monitoring plan is essential

Key Takeaway

Incidental discovery doesn't automatically mean better or worse prognosis. What matters is:

• What the cancer looks like (Gleason score, stage, PSA)
• How long you're expected to live (life expectancy)
• Your personal preferences about treatment vs. monitoring

According to NCCN Guidelines, many patients with incidentally discovered, low-risk prostate cancer can safely pursue active surveillance or observation without immediate treatment—and some may never need treatment. However, this depends entirely on your specific cancer characteristics and life expectancy.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.